Improving health outcomes globally
On behalf of the Federal Ministry for Economic Cooperation and Development KfW is investing EUR 10 million in the guaranteed by the . The GHIF, which has a target size of USD 100 million, is an innovative financing instrument in the health sector and is also attractive for private investors.
The GHIF funds the development and launch of new medicines, vaccines, diagnostic instruments and family planning products in developing countries. In the later stages of clinical studies pharmaceutical companies, research institutes and government institutions are able to apply for funding to use these products to fight disease. The focus is on health products which can be used to treat diseases prevalent among poorer sections of the population which pharmaceutical companies do not have an incentive to invest in combatting in the absence of subsidies.
Positions and projects
As of July 2015